Provider review
Nex Gen Health Rx Review: It Names Its Pharmacy, and Invents a Credential For It
Nex Gen Health Rx does the thing this category almost never does: it names the pharmacy that fills your prescription, Manifest Pharmacy of Greer, South Carolina, with a street address in the footer of every page. Then it puts "503A accredited pharmacies" under every product, and there is no such accreditation — a 503A pharmacy is licensed by a state board and nothing accredits it. Of its four peptide claims, one names a mechanism the trials measured and three name outcomes nobody has tested.
It names the pharmacy, which almost nobody does — and then badges it with an accreditation that does not exist under the section it cites.
Worth trusting if
- You want the dispensing pharmacy named, with an address you can check against a state board
- You want PT-141 from a page that describes the mechanism correctly, if not the population
- You want a company that carries the state-specific consumer notices four states require
Be skeptical if
- You live in Louisiana, the one state its checkout will not ship to
- You want a certificate of analysis for what you are injecting, because none is published
- You are relying on "503A accredited" to mean something, because it does not
Compounded only
Phase 3 trials
Named
None found
Disclosure: Some links on this site are affiliate or referral links. If you start a treatment or buy a product through them, we may earn a commission at no additional cost to you. Read our full disclosure.
Opens nexgenhealthrx.com. A link is not a recommendation to take anything.
Provenance
What Nex Gen Health Rx actually dispenses
Regulatory category is the axis consumers are most reliably misled about, so it comes first. Every product below is sorted by what it legally is, not by what it costs.
Prepared by a state-licensed pharmacy against a prescription for a named patient. Compounded preparations are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.
- Sermorelin — Published as "Starting at $195 Per Month" on a selector offering 30-, 90-, 180- and 360-day supplies. The site does not say which tier that floor belongs to.
- NAD+ Injectable — Published as "Starting at $299 Per Month" — the dearest product in this range, more than five times the glutathione beside it, with no explanation of the gap.
- Glutathione — Published as "Starting at $57.32 Per Month", the cheapest peptide here — and quoted to the cent, which no other product on the site is.
- PT-141 — Published as "Starting at $189 Per Month".
Evidence
Has the molecule been tested for what it is sold for?
One row per product, graded on how far the published human evidence goes for the MOLECULE inside it, for the use it is sold for — not for the molecule in general, and never a claim about this seller. Nobody trials a compounded preparation; what a trial can tell you is whether the molecule has been tested for the thing it is being advertised to do. A molecule with phase 3 evidence for one outcome has none for another, and that distinction is where peptide marketing lives.
1
Molecules with human evidence
For the use they are sold for, out of 4 products reviewed here. The evidence belongs to the molecule, not to Nex Gen Health Rx.
2
Registry records cited
Each read live from ClinicalTrials.gov, never from memory. None of them tested this company's product.
The comparison
What they claim, against what the trials show
Each claim below is quoted verbatim from Nex Gen Health Rx’s own page, with the page it came from. Grading a paraphrase would prove nothing. Every row is the verdict at a glance — tap it to open the quote, the trial registry entries, and the full note behind that verdict.
SermorelinSermorelin · Compounded (503A)Claim reaches past the trials
“A growth-hormone releasing peptide that stimulates your own pituitary — supporting sleep, recovery and body composition.”
Read on the Nex Gen Health Rx site, September 2026
No trial for this use
What the trials show for Sermorelin
As of August 2026, a PubMed search for sermorelin filtered to the randomized-controlled-trial publication type returned 19 records, the most recent published in 2005. Every one measures growth hormone secretion, growth in children, or the response to a diagnostic challenge. None tests sleep, recovery or body composition as an outcome in healthy adults. A parallel ClinicalTrials.gov search returned 27 studies; the two closest to the marketed use are both phase 2 and both terminated, at 13 and 5 participants.
Everything before the dash is accurate and everything after it is untested. Sermorelin does release growth hormone by acting on the pituitary — that is the mechanism, and it is what all nineteen randomized trials measured. Sleep, recovery and body composition were an outcome in none of them. The dash is doing a lot of work: it reads as though the second clause follows from the first, and no trial has shown that it does.1
NAD+ InjectableNAD+ (nicotinamide adenine dinucleotide) · Compounded (503A)No trial supports this claim
“Nicotinamide adenine dinucleotide — a coenzyme central to mitochondrial function and cellular repair. […] Fuel your cells. Feel the difference. NAD+ is a coenzyme central to energy production, DNA repair.”
Read on the Nex Gen Health Rx site, September 2026
No trial for this use
As of August 2026, a ClinicalTrials.gov intervention search for injected NAD+ in humans returns no completed randomized trial supporting a restoration-of-function claim, and a PubMed search for nicotinamide adenine dinucleotide combined with injection or subcutaneous, filtered to the randomized-controlled-trial publication type, returns zero records. The substantial human literature concerns ORAL precursors — nicotinamide riboside and nicotinamide mononucleotide — which are different molecules by a different route.
"A coenzyme central to mitochondrial function" is textbook cell biology and is true of the molecule sitting in every cell you already have. "Feel the difference" is a promise about what happens when you inject more of it, and no completed randomized trial of injected NAD+ in humans has measured energy, repair or anything else. The page moves from biochemistry to a felt effect in two sentences, with nothing in between.2
GlutathioneGlutathione · Compounded (503A)No trial supports this claim
“The body's master antioxidant — supports detoxification, immune function and skin clarity.”
Read on the Nex Gen Health Rx site, September 2026
No trial for this use
What the trials show for Glutathione
As of August 2026, a PubMed search for glutathione in title or abstract, combined with an injected route and with skin, detoxification, fatigue or energy, restricted to the randomized-controlled-trial publication type, returned seven records. Not one tests injected glutathione on its own for any of those outcomes. On ClinicalTrials.gov, 268 studies list glutathione as an intervention; restricting to injected routes returns three, in mantle-cell lymphoma, acute liver failure and pneumonia.
Three outcomes, none of them tested for this product. "The body's master antioxidant" is a description of the molecule's role inside a cell; detoxification, immune function and skin clarity are things an injection would have to be shown to do, and the seven randomized records a targeted search returns test something else entirely. Skin clarity in particular is a cosmetic outcome with a substantial market and no trial behind an injected version.3
PT-141Bremelanotide (PT-141) · Compounded (503A)Claim reaches past the trials
“Works centrally on the brain's arousal pathways — for both men and women who want to reignite desire. […] PT-141 (Bremelanotide) works on the central nervous system to enhance sexual response.”
Read on the Nex Gen Health Rx site, September 2026
Phase 3 trials
What the trials show for Bremelanotide (PT-141)
- NCT02333071 RECONNECT Study 1 — Phase 3, completed, n=723. Premenopausal women with hypoactive sexual desire disorder — one of the two trials behind the FDA approval of bremelanotide.
- NCT02338960 RECONNECT Study 2 — Phase 3, completed, n=714. The identical second trial, in the same population.
The mechanism is right and the population is half wrong. Bremelanotide does act centrally rather than on blood flow, which distinguishes it from the erectile-dysfunction drugs this site sells beside it, and "desire" is the correct outcome — it is what RECONNECT measured. What those two trials enrolled was 1,437 premenopausal WOMEN with hypoactive sexual desire disorder. "For both men and women" attaches half its claim to a population the evidence does not cover, and the page never mentions that an approved version of this molecule exists.4
Dispensing chain
Who actually fills your prescription
- Manifest Pharmacy — 1018 S. Batesville Road, Greer, SC 29650, named in the footer of every page and on the returns policy
Read the full account
Nex Gen names its dispensing pharmacy with a street address, in the footer of every page — a real disclosure that most of this category will not make, and one a reader can check against a state board. What sits beside it is not real: every product page badges "503A accredited pharmacies", and no accreditation exists under that section. A 503A pharmacy is licensed by a state board of pharmacy and FDA grants it no status at all. The FAQ is more careful than the badge, saying "licensed, accredited U.S. pharmacies, including 503A compounding pharmacies", which at least keeps the accreditation and the section number apart. No legal entity is published for Nex Gen itself anywhere on the site, and no prescriber or medical group is named.
Read on the Nex Gen Health Rx site, September 2026.
Quality
Third-party testing, and what is published
Describes a testing regime
Nothing published on the pages searched
Certificate of analysis readable
No lot report a buyer can open
Read the full testing account
No certificate of analysis, potency, purity or sterility result is published for any of the four peptides. The only quality statement is the badge itself — "503A accredited pharmacies" — which asserts a credential that does not exist rather than a test that was run. That is the sharper version of a common failure: most sellers here publish nothing and claim nothing; this one publishes nothing and claims a designation.
Read on the Nex Gen Health Rx site, September 2026.
Licensing
Licensed to dispense, and where
Coverage
Nex Gen publishes no state list of its own — its FAQ says only that it serves "patients in most U.S. states" and confirms eligibility during intake. The one enumerable answer is its checkout shipping selector, read on September 1, 2026: 50 entries covering 49 states and the District of Columbia, with Louisiana the single absence. That is the set of addresses the checkout will accept rather than a sentence the company writes.
Read the full licensing claim
"U.S. board certified physicians", "confidential online consultation" and "503A accredited pharmacies" on every product page. Its terms also carry the state-specific consumer notices Florida, California, Texas and Kansas require. No license number or prescriber name is published.
Named as outside that footprint
Read on the Nex Gen Health Rx site, September 2026.
Regulatory
The FDA warning letter
Checked, and none found
Assessment
What holds up, and what does not
- It names its dispensing pharmacy — Manifest Pharmacy, Greer, South Carolina — with a street address in the footer of every page.
- Its sermorelin page describes the mechanism accurately: a growth-hormone releasing peptide that stimulates your own pituitary.
- Its PT-141 page gets the mechanism right too, distinguishing a central action on desire from the blood-flow drugs it sells alongside.
Show 4 more
- All four peptide prices are visible on public product pages before any account or questionnaire.
- Its terms carry the state-specific consumer notices Florida, California, Texas and Kansas require, which is more compliance work than most of this category does.
- Its FAQ separates accreditation from the section number, even where its product badge does not.
- No FDA warning letter for the trade name or for the pharmacy it names.
- "503A accredited pharmacies" appears on every product page. No accreditation exists under that section — a 503A pharmacy is licensed by a state board and FDA grants it no status.
- Three of its four peptide claims name outcomes no trial has tested: sleep, recovery and body composition for sermorelin; detoxification, immune function and skin clarity for glutathione; energy and repair for injected NAD+.
- Its NAD+ page moves from cell biology to "Feel the difference" in two sentences, with no trial in between.
Show 7 more
- "For both men and women" on PT-141 attaches half the claim to a population the two phase 3 trials did not enroll.
- No certificate of analysis, potency or purity result is published for any peptide.
- No legal entity is published anywhere — no LLC, Inc. or PLLC on any page or in either bundle, on a site taking payment for prescription medication.
- Every price is a "starting at" floor on a four-tier supply selector, and the site never says which tier the floor belongs to.
- NAD+ is the dearest product in the range at more than five times the glutathione beside it, with no explanation.
- Its own NAD+ product URL is inconsistent: one path returns "Product not found" while the live page sits at another.
- No prescriber or medical group is named anywhere.
Verdict
The bottom line
Take the pharmacy disclosure seriously and the badge underneath it not at all. Manifest Pharmacy is named with an address, which means you can check it against a state board and ask it directly for a certificate of analysis — something this site does not publish for any of its four peptides. Then read the claims twice: the sermorelin and PT-141 pages describe their mechanisms correctly and then extend them to outcomes and populations no trial has covered, and the glutathione and NAD+ pages start from cell biology and end at a felt effect.
Opens nexgenhealthrx.com. A link is not a recommendation to take anything.
What it gets right first
Nex Gen names its pharmacy.
Nex Gen Health Rx / Manifest Pharmacy, 1018 S. Batesville Road, Greer, SC 29650
That is in the footer of every page and on the returns policy, and it changes what a reader can do. A named pharmacy can be looked up against its state board, checked for disciplinary history and asked directly for a certificate of analysis. "Our trusted pharmacy partners", the standard phrasing across this category, can be none of those things.
Full analysis — 4 more sectionsAnd then the badge · Four claims · The prices are floors on a ladder nobody explains · What is not published
And then the badge
Directly beneath the buy button on every product page:
"503A accredited pharmacies"
There is no such accreditation.
503A is the section of the Food, Drug, and Cosmetic Act covering a preparation compounded by a state-licensed pharmacy against a prescription for one named patient. The license comes from a state board of pharmacy. FDA grants a 503A compounder no status of any kind — not approval, not registration, not accreditation.
This is the second seller in this sweep to invent a credential in this exact shape. NEUVÉ Health writes "503A and 503B certified pharmacies"; Nex Gen writes "503A accredited". Different words, same maneuver: taking a section number that describes a legal category and attaching a quality label to it that nobody issues.
Its own FAQ is more careful than its badge — "licensed, accredited U.S. pharmacies, including 503A compounding pharmacies" at least keeps the two ideas apart. The badge a buyer sees at the point of purchase does not.
Four claims
Sermorelin — "A growth-hormone releasing peptide that stimulates your own pituitary — supporting sleep, recovery and body composition."
Everything before the dash is correct. Sermorelin acts on the pituitary and releases growth hormone; that is what all nineteen randomized trials measured. 1 Nothing after the dash was an outcome in any of them.
PT-141 — "Works centrally on the brain's arousal pathways — for both men and women."
The mechanism is right, and getting it right matters here: bremelanotide acts centrally on desire rather than on blood flow, which genuinely distinguishes it from the erectile-dysfunction drugs sold two menu items away. The trials enrolled 1,437 premenopausal women. 4 Half of "for both men and women" is outside them.
Glutathione — "The body's master antioxidant — supports detoxification, immune function and skin clarity."
The first clause is cell biology. The three that follow are outcomes an injection would have to be shown to produce, and a targeted search of the randomized literature returns seven records, none of which tests injected glutathione on its own. 3
NAD+ — "a coenzyme central to mitochondrial function and cellular repair … Fuel your cells. Feel the difference."
Two sentences, and the distance between them is the whole problem. The first is true of the NAD+ already in every cell you have. The second is a promise about injecting more, and no completed randomized trial in humans has tested it. 2
The prices are floors on a ladder nobody explains
Every peptide is published as "Starting at $X Per Month" above a selector offering 30-, 90-, 180- and 360-day supplies. The site never says which tier the floor describes.
That matters because our sibling cost site established the same pattern on this company's GLP-1 line: a homepage figure of "as low as $99 a month" that turns out to require $1,188 charged upfront, explained only in footer fine print on a different page.
One oddity worth noting: NAD+ at $299 a month is the dearest product in the peptide range and more than five times the glutathione beside it. Nothing on the site accounts for the gap.
What is not published
No certificate of analysis. No potency, purity or sterility result. No prescriber or medical group. And no legal entity for Nex Gen itself — a census across thirteen pages and both production bundles found no LLC, Inc. or PLLC anywhere.
That last absence has a consequence for this review, and we would rather state it than let a clean result imply more than it should: our FDA warning-letter screen matches on name. With no legal entity published, a clean screen covers the trade name and the pharmacy, and nothing else.
Questions
Frequently asked questions
Is "503A accredited" a real credential?
No. 503A describes a preparation compounded by a state-licensed pharmacy against a prescription for one named patient. The license comes from a state board of pharmacy, and no body accredits pharmacies under that section — FDA grants a 503A compounder no status at all. Nex Gen's own FAQ separates the two ideas more carefully than the badge on its product pages does.
Which pharmacy fills a Nex Gen prescription?
Manifest Pharmacy of Greer, South Carolina, named with a street address in the footer of every page. That is a genuine disclosure and unusual in this category — it means you can check the pharmacy against its state board and ask it directly for a certificate of analysis, which this site does not publish.
Which of its peptide claims holds up?
The mechanisms do; the outcomes mostly do not. Sermorelin does release growth hormone and PT-141 does act centrally on desire — both accurate. Sleep, recovery and body composition for sermorelin have no trial behind them, and PT-141's two phase 3 trials enrolled only women, which is half of what that page claims.
Why is NAD+ the most expensive product here?
Nothing on the site says. At "Starting at $299 Per Month" it is the dearest thing in the peptide range and more than five times the glutathione listed beside it, and it is also the product with the least human evidence behind it — no completed randomized trial of injected NAD+ exists.
Does Nex Gen publish test results?
No certificate of analysis, potency or purity result appears for any of its four peptides. Since it names its pharmacy, a buyer at least has somebody to ask — which is more than most of this category offers, and less than publishing one.
Glossary
Key terms
Show definitions
- 503A
- The section covering a preparation compounded by a state-licensed pharmacy against a prescription for one named patient. The pharmacy is licensed by a state board; there is no 503A accreditation and FDA grants no status under it.
- Master antioxidant
- A description of glutathione's role inside a cell. It is a fact about biochemistry and says nothing about whether injecting glutathione produces an effect a person would notice.
Compare
Others selling what Nex Gen Health Rx sells
Companies we have also reviewed that dispense at least one of the same compounds, ordered by how much of what they say about their products matches the trials behind them. Nothing here is a recommendation, and none of these links earns us anything.
- Belle HealthAlso sells Sermorelin · 3 of 3 claims match the trials
- Pallas HealthAlso sells NAD+ (nicotinamide adenine dinucleotide) · 4 of 4 claims match the trials
- ShedAlso sells Sermorelin · 4 of 6 claims match the trials
- CareBareRXAlso sells NAD+ (nicotinamide adenine dinucleotide) · 2 of 4 claims match the trials
Method
How we checked this
Non-product facts last checked September 2026. Read the editorial policy for the rules this page is held to.
Read our methodology
Claims read first-party
Every quoted claim was read off Nex Gen Health Rx's own pages, first-hand, on the date stamped against it — never from a summary, an aggregator, or an earlier version of this review.
Trials read from the registry
Phase, status and enrollment come from ClinicalTrials.gov; identifiers and journals from PubMed's own records. Nothing here is cited from memory.
Absence claims bounded
Where we report that no trial exists, the page says what was searched, where, and when — never an unbounded claim that nobody has tested something.
Letters matched on full name
FDA letters are matched on the complete company name. A substring match would attach one firm's regulatory history to another with a similar name.
Sources
References
Show all 4 sources
- US National Library of Medicine (2026). PubMed search: sermorelin AND randomized controlled trial[pt] — 19 records, most recent 2005; ClinicalTrials.gov intervention "sermorelin" — 27 studies. PubMed / ClinicalTrials.gov. https://pubmed.ncbi.nlm.nih.gov/?term=sermorelin+AND+randomized+controlled+trial%5Bpt%5D
- US National Library of Medicine (2026). PubMed search: nicotinamide adenine dinucleotide AND (injection OR subcutaneous) AND randomized controlled trial[pt] — zero records for injected NAD+ in humans. PubMed. https://pubmed.ncbi.nlm.nih.gov/?term=nicotinamide+adenine+dinucleotide+AND+injection+AND+randomized+controlled+trial%5Bpt%5D
- US National Library of Medicine (2026). PubMed search: glutathione[tiab] AND injected route AND (skin OR detoxification OR fatigue OR energy) AND randomized controlled trial[pt] — 7 records, none testing injected glutathione alone; ClinicalTrials.gov injected-route glutathione — 3 studies, in lymphoma, acute liver failure and pneumonia. PubMed / ClinicalTrials.gov. https://pubmed.ncbi.nlm.nih.gov/?term=glutathione%5Btiab%5D+AND+randomized+controlled+trial%5Bpt%5D
- Kingsberg SA, Clayton AH, Portman D, Williams LA, et al. (2019). Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials. Obstetrics & Gynecology 134(5):899-908. https://pubmed.ncbi.nlm.nih.gov/31599840/
Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.